Lilly and Amgen alum. Currently at Apellis, a growing biotech start-up and scientific leader in complement. Commercialization expertise in early pipeline and late-stage assets in both population driven disease areas and rare-disease. Solid tumor oncology, rare hematological disease, and diabetes experience.
Invited by: Marcelo HD
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
February 05, 2024 | 26 | -1 | -3.8% |
March 07, 2023 | 27 | 0 | 0.0% |
December 13, 2021 | 27 | +1 | +3.9% |
November 05, 2021 | 26 | +2 | +8.4% |
September 28, 2021 | 24 | +1 | +4.4% |
August 07, 2021 | 23 | +4 | +21.1% |